Clinical trial
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
NCT01066364 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- February 29, 2012
- Enrollment
- 59 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
nonalcoholic steatohepatitis